Course of Ovarian Hyperstimulation Syndrome in 19 Intact Twin Pregnancies After Assisted Reproduction Techniques, With a Case Report of Severe Thromboembolism

Abstract Ovarian hyperstimulation syndrome (OHSS) is a serious complication of assisted reproduction techniques using in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI). Its etiology has still not yet been fully resolved. Human chorionic gonadotrophin, administered exogenously as well as produced endogenously during pregnancy, is responsible for the onset of OHSS, and high levels of estradiol appear to worsen the condition. In this case series, the course of mild to severe OHSS was evaluated in 19 intact twin pregnancies after IVF/ICSI. Another serious complication associated with OHSS is thromboembolic events. In these cases, the pregnancy can be protected through anticoagulation treatment, but there may be exceptions to this. This series includes a case of bilateral thrombosis of the internal and external jugular veins in the 7th gestational week in a twin pregnancy after OHSS and ICSI, with termination of the pregnancy in the 9th gestational week due to progressive thrombosis during anticoagulation therapy.

[1]  U. Chitkara,et al.  Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. , 2005, Human reproduction.

[2]  A. Pinborg.  IVF/ICSI twin pregnancies: risks and prevention. , 2005, Human reproduction update.

[3]  E. Schiff,et al.  Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. , 2005, Human reproduction.

[4]  A. Pinborg,et al.  Neonatal outcome in a Danish national cohort of 8602 children born after in vitro fertilization or intracytoplasmic sperm injection: the role of twin pregnancy , 2004, Acta obstetricia et gynecologica Scandinavica.

[5]  M. Stephenson,et al.  Pharmacokinetics of Low Molecular Weight Heparin and Unfractionated Heparin in Pregnancy , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[6]  A. Müller,et al.  Ovarielles Überstimulationssyndrom-update - Teil 1 , 2004 .

[7]  G. Greisen,et al.  Neonatal outcome in a Danish national cohort of 3438 IVF/ICSI and 10,362 non-IVF/ICSI twins born between 1995 and 2000. , 2004, Human reproduction.

[8]  L. Barbour,et al.  A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. , 2003, American journal of obstetrics and gynecology.

[9]  D. Back,et al.  A Longitudinal Study of Maternal Dose Response to Low Molecular Weight Heparin in Pregnancy , 2003, Obstetrics and gynecology.

[10]  L P Hunt,et al.  Distinction between early and late ovarian hyperstimulation syndrome. , 2000, Fertility and sterility.

[11]  J. Ray,et al.  Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. , 1999, Obstetrical & gynecological survey.

[12]  J. Schenker,et al.  Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. , 1998, Fertility and sterility.

[13]  J. Spence,et al.  Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. , 1995, Human reproduction.

[14]  A A Connolly,et al.  Deep vein thrombosis. , 1988, BMJ.

[15]  Serge Rozenberg,et al.  Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). , 2003, Human reproduction update.